Page 5,855«..1020..5,8545,8555,8565,857..5,8605,870..»

Some children 'grow out of autism', study of 34 children finds

Posted: Published on January 15th, 2013

Autism is a condition some children grow out of, a study has indicated. Experts studied 34 school-age children and young adults who had been diagnosed with autism early in life but now appeared to be functioning normally. Tests confirmed that the group, aged eight to 21, no longer suffered symptoms of the developmental condition that makes it difficult to communicate and socialise. The results, published in the Journal of Child Psychology and Psychiatry, provide no estimate of the proportion of children likely to recover from autism. Dr Thomas Insel, director of the US National Institute of Mental Health which supported the study, said: Although the diagnosis of autism is not usually lost over time, the findings suggest that there is a very wide range of possible outcomes. For an individual child, the outcome may be knowable only with time and after some years of intervention. Subsequent reports from this study should tell us more about the nature of autism and the role of therapy and other factors in the long term out come for these children. Previous studies looking at the likelihood of autism recovery have proved inconclusive. Questions remained over the accuracy of the original diagnosis, and whether children … Continue reading

Comments Off on Some children 'grow out of autism', study of 34 children finds

Children can GROW OUT of autism, claim scientists

Posted: Published on January 15th, 2013

Autistic children who recovered appeared to have milder social difficulties but more repetitive behaviours By studying children who appear to grow out of the disorder experts hope to create better therapies By Claire Bates PUBLISHED: 12:13 EST, 15 January 2013 | UPDATED: 13:36 EST, 15 January 2013 Autism is a condition some children manage to grow out of, a study has shown. Experts studied 34 school-age children and young adults who had been diagnosed with autism early in life but now appeared to be functioning normally. Tests confirmed that the group, aged eight to 21, no longer suffered symptoms of the developmental condition that makes it difficult to communicate and socialise. Autistic children who recovered appeared to have milder social difficulties but more repetitive behaviours The results, published in the Journal of Child Psychology and Psychiatry, provide no estimate of the proportion of children likely to recover from autism. But the researchers say they offer hope that in at least some cases, the handicap of autism can be left behind. More here: Children can GROW OUT of autism, claim scientists … Continue reading

Comments Off on Children can GROW OUT of autism, claim scientists

Study Identifies 24 New Autism-Related Gene Variants

Posted: Published on January 15th, 2013

Newswise (SALT LAKE CITYUniversity of Utah (the U) researchers, in collaboration with several groups from around the country, published a paper on Monday, Jan. 14, 2013, following one of the biggest studies of its kind, that extends our understanding of genes related to autism spectrum diseases (ASDs) and advances methods for early detection and treatment. Nori Matsunami, M.D., Ph.D., a research scientist in the Department of Human Genetics at the U, was one of the three lead authors who contributed equally to the paper and worked with Mark Leppert, Ph.D., a distinguished professor in the Department of Human Genetics. With colleagues from the Childrens Hospital of Philadelphia (CHOP), Lineagen Inc. (Salt Lake City) and Golden Helix Inc. (Bozeman, Mont.), the study identifies 24 new copy number variants (CNVs) missing or duplicated stretches of DNA with a strong link to autism. Utah has long been leading the way in disease-relevant genetic discoveries, Leppert said. The newly identified variants were discovered based on CNVs and gene sequence variants originally found in multigenerational Utah ASD families. The ability to replicate the association in a second, large ASD population is a major step forward in understanding the genetic markers associated with ASD. Startup company … Continue reading

Comments Off on Study Identifies 24 New Autism-Related Gene Variants

Some children 'grow out of autism'

Posted: Published on January 15th, 2013

Autism is a condition some children manage to grow out of, a study has shown. Experts studied 34 school-age children and young adults who had been diagnosed with autism early in life but now appeared to be functioning normally. Tests confirmed that the group, aged eight to 21, no longer suffered symptoms of the developmental condition that makes it difficult to communicate and socialise. The results, published in the Journal of Child Psychology and Psychiatry, provide no estimate of the proportion of children likely to recover from autism, but the researchers say they offer hope that, in at least some cases, the handicap of autism can be left behind. Dr Thomas Insel, director of the US National Institute of Mental Health which supported the study, said: "Although the diagnosis of autism is not usually lost over time, the findings suggest that there is a very wide range of possible outcomes. "For an individual child, the outcome may be knowable only with time and after some years of intervention. Subsequent reports from this study should tell us more about the nature of autism and the role of therapy and other factors in the long-term outcome for these children." Previous studies looking … Continue reading

Comments Off on Some children 'grow out of autism'

24 new autism-related gene variants identified

Posted: Published on January 15th, 2013

Washington, January 15 (ANI): In a new study, researchers have extended out understanding of genes related to autism spectrum diseases (ASDs) and advances methods for early detection and treatment. Nori Matsunami, one of the three lead authors from the University of Utah (the U), contributed equally to the paper and worked with Mark Leppert. With colleagues from the Children's Hospital of Philadelphia (CHOP), Lineagen Inc. (Salt Lake City) and Golden Helix Inc. (Bozeman, Mont.), the study identifies 24 new copy number variants (CNVs) - missing or duplicated stretches of DNA - with a strong link to autism. "Utah has long been leading the way in disease-relevant genetic discoveries," Leppert said. "The newly identified variants were discovered based on CNVs and gene sequence variants originally found in multigenerational Utah ASD families. The ability to replicate the association in a second, large ASD population is a major step forward in understanding the genetic markers associated with ASD," he said. Startup company Lineagen, Inc., which launched in 2002 based on U technology, is providing a related test for ASD diagnosis. The study validates the genetic markers used in this test. The product, called FirstStepDx PLUS, tests for many ASD markers, including the 24 … Continue reading

Comments Off on 24 new autism-related gene variants identified

UCI research turns the corner on autism

Posted: Published on January 15th, 2013

Public release date: 15-Jan-2013 [ | E-mail | Share ] Contact: Tom Vasich tmvasich@uci.edu 949-824-6455 University of California - Irvine Irvine, Calif. With $14 million from the William & Nancy Thompson Family Foundation and the Children & Families Commission of Orange County, UC Irvine is helping lead the charge against a disorder that affects about 1 in 88 children in the U.S. autism. The funding created the Center for Autism & Neurodevelopmental Disorders of Southern California, which will provide unparalleled access to assessment, diagnosis, care coordination, family support and education for children, teens and young adults. Along with facilitating this continuum of care, the generous funding will augment an aggressive UC Irvine research campaign to find new treatments that is affiliated with the new center. "In addition to all that the Center for Autism & Neurodevelopmental Disorders of Southern California will offer, we must stand behind world-class research," says William Thompson, chairman of the William & Nancy Thompson Family Foundation. "This is taking place right now at UC Irvine. Real breakthroughs must start with research that is directed toward novel treatment approaches, and the research team at UC Irvine is distinctively set up to do this. These efforts walk hand … Continue reading

Comments Off on UCI research turns the corner on autism

Covidien Begins SWIFT PRIME Study

Posted: Published on January 15th, 2013

International health care product major, Covidien plc. (COV), has initiated a new study, SWIFT PRIME. The main objective of this study is to find out the efficacy of the Solitaire FR Revascularization Device to treat acute ischemic stroke. Stroke is the fourth leading cause of death in the U.S., according to the American Heart Association. Ischemic stroke occurs when a blood vessel carrying oxygen and nutrients to the brain is clogged. The Solitaire FR device, an overlapping stent-based technology, mechanically removes blood clots from blocked vessels, restoring blood flow to the brain in patients ailing from stroke. The device has won the approval of the U.S. Food and Drug Administration (FDA) in March 2012 and is already approved outside the U.S. for the endovascular treatment of acute ischemic stroke, offering physicians with an innovative treatment technology over the existing therapy options. The new clinical trial has enrolled its first patient at the Buffalo University and may enroll roughly 800 patients across 60 medical centers worldwide. Deemed to be one of the largest global medical studies, it will examine the effectiveness of mechanical thrombectomy using the Solitaire device in stroke care. The trial will also incorporate a health economic analysis. The … Continue reading

Comments Off on Covidien Begins SWIFT PRIME Study

New technique helps stroke victims communicate

Posted: Published on January 15th, 2013

Jan. 15, 2013 Stroke victims affected with loss of speech caused by Broca's aphasia have been shown to speak fluidly through the use of a process called "speech entrainment" developed by researchers at the University of South Carolina's Arnold School of Public Health. Aphasia, a severe communication problem caused by damage to the brain's left hemisphere and characterized by halting speech, occurs in about one-third of people who have a stroke and affects personal and professional relationships. Using the speech entrainment technique, which involves mimicking other, patients showed significant improvement in their ability to speak. The results of the study are published in a recent issue of the neurology journal Brain. "This is the first time that we have seen people with Broca's aphasia speak in fluent sentences," said Julius Fridriksson, the study's lead researcher and a professor with the Department of Communication Sciences and Disorders at the Arnold School. "It is a small study that gives us an understanding of how the brain functions after a stroke, and it offers hope for thousands of people who suffer strokes each year." In Fridriksson's study, 13 patients completed three separate behavioral tasks that were used to understand the effects of speech … Continue reading

Comments Off on New technique helps stroke victims communicate

Ohio State spinal injury research could promote recovery

Posted: Published on January 15th, 2013

People with spinal cord injuries have reason to be more optimistic about recovery after the recent publication of new findings from an Ohio State professor. The experimental drug LM11A-31 was developed by Sung Ok Yoon, an associate professor of molecular and cellular biochemistry at OSU, along with co-author Frank Longo, professor of neurology and neurological sciences at Stanford University. This is the first oral drug to improve functional movement in rodents after a spinal cord injury without any additional means of therapy, such as an invasive procedure, Yoon said. Often invasive measures are used to treat spinal cord injuries, like drilling a hole in the brain to deliver the drug. Our goal was to find non-invasive therapy that could be taken orally or simply injected into the arm, Yoon said. A protein called p75 is linked to the death of specialized cells following a spinal cord injury. Yoon and Longos developmental drug targets this protein to prevent degeneration, Yoon said. Throughout the study, Yoon and her fellow researchers administered three different doses of the drug as well as a placebo to mice about four hours after injury. They continued this treatment twice a day for 42 days. During this time, … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Ohio State spinal injury research could promote recovery

Neuralstem Obtains FDA Approval To Commence Spinal Cord Injury Trial

Posted: Published on January 15th, 2013

By RTT News, January 14, 2013, 11:01:00 AM EDT (RTTNews.com) - Neuralstem Inc. ( CUR ) announced Monday that it received approval from the United States Food and Drug Administration or FDA to commence a Phase I safety trial of its lead cell therapy candidate, NSI-566, in chronic spinal cord injury patients. This open-label, multi-site study, will enroll up to eight patients with thoracic spinal cord injuries (T2-T12), who have an American Spinal Injury Association or AIS A level of impairment, between one and two years after injury. AIS A impairment refers to a patient with no motor or sensory function in the relevant segments at and below the injury, and is considered to be complete paralysis. The primary objective of the study is to determine the safety and toxicity of human spinal stem cell transplantation for the treatment of paralysis and related symptoms due to chronic spinal cord injury (SCI). The secondary objectives of the study are to evaluate graft survival in the transplant site by MRI, as well as the effectiveness of transient immunosuppression. Additionally, the study will look at exploratory objectives to evaluate the ability of human spinal cord stem cell or HSSC transplantation to positively affect … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Neuralstem Obtains FDA Approval To Commence Spinal Cord Injury Trial

Page 5,855«..1020..5,8545,8555,8565,857..5,8605,870..»